[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filed a Form 144 to notify the proposed sale of 50,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $5,011,000.00. The filing states these shares are founders' shares acquired on 11/13/2017. The company reports 370,470,348 shares outstanding, and the approximate date of sale is listed as 09/10/2025. The filing also discloses prior dispositions in the past three months: a 10b5-1 sale of 32,455 shares (gross proceeds $3,104,307.77) and a 10b5-1 sale of 50,000 shares (gross proceeds $4,782,480.00).

Positive

• Disclosure compliance: Form 144 filed to publicly notify proposed sale, supporting market transparency
• Use of 10b5-1 plans: Prior 10b5-1 sales are disclosed, indicating pre-established trading arrangements

Negative

• Insider selling: Proposed sale plus recent 10b5-1 sales total material insider dispositions (82,455 shares in past months)
• Founder share liquidation: Sale originates from founders' shares, which may signal ownership reduction even if small versus outstanding shares

Insights

Securities Analyst

TL;DR: Insider-related sale of 50,000 founder shares is disclosed; amounts are small relative to outstanding shares and consistent with prior 10b5-1 sales.

The Form 144 documents a proposed brokered sale of 50,000 common shares with an aggregate market value of $5,011,000, originating from founder shares acquired in 2017. The filing notes recent 10b5-1 program sales totaling 82,455 shares in late August 2025, indicating the seller has been reducing holdings under trading plans. Relative to the issuer's reported 370,470,348 shares outstanding, the proposed sale represents a de minimis portion of the float. This disclosure is procedurally important for market transparency but does not by itself indicate a material change to company capitalization or control.

Corporate Governance Expert

TL;DR: The filing shows compliance with Rule 144 and notes use of 10b5-1 plans; signer attests no undisclosed material adverse information.

The Form 144 format and accompanying remarks emphasize the seller's representation that no material nonpublic information is known and reference Rule 10b5-1 trading plans. The disclosure of the acquisition date (11/13/2017) and the nature of the shares (founders' shares) provides governance context about the origin of the securities. From a governance perspective, the filing demonstrates adherence to required insider-sale notice procedures and public transparency about insider dispositions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	5011000.00	370470348	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			50000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	32455	3104307.77
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	50000	4782480.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CoreWeave (CRWV) disclose?

The Form 144 notifies a proposed sale of 50,000 common shares with an aggregate market value of $5,011,000.00 via Morgan Stanley Smith Barney LLC.

When were the shares being sold originally acquired?

The shares were acquired on 11/13/2017 and are described as founders' shares.

How many CoreWeave shares are outstanding according to the filing?

The filing lists 370,470,348 shares outstanding.

Has the seller previously sold shares recently?

Yes. The filing discloses 10b5-1 sales on 08/27/2025 of 32,455 shares (gross proceeds $3,104,307.77) and 50,000 shares (gross proceeds $4,782,480.00).

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.